Resources

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (September 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

Presentations from the 2019 MS Summit

View Presentations here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (June 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (April 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

MS Coalition Brochure (January 2012)

The Multiple Sclerosis Coalition (MSC) was founded in 2005 by three independent multiple sclerosis (MS) organizations in an effort to work together to benefit individuals with MS. Since that time, the MSC has grown to nine member organizations, all of whom provide critical MS programs and services.    Download here

Follow us on Twitter

TwitterFollow

MS Coalition
Retweet on TwitterMS Coalition Retweeted
mssocietyNational MS Society@mssociety·
25 Feb

#ACTRIMS Prof. Dwight Bergles accepts 2020 Barancik Prize for Innovation in #MSResearch; pioneered visualization of immature brain cells that hold key to restoring function in people with #MultipleSclerosis; we can view cells in real time thanks to his work.

Reply on Twitter 1365003595574296580Retweet on Twitter 13650035955742965804Like on Twitter 136500359557429658016Twitter 1365003595574296580
Retweet on TwitterMS Coalition Retweeted
iConquerMSiConquerMS@iConquerMS·
25 Feb

Join the movement of people living with #MS that are helping to drive research forward towards new treatments and cures. Learn more or sign up at http://www.iConquerMS.org #MultipleSclerosisResearch

Reply on Twitter 1364979782186917891Retweet on Twitter 13649797821869178912Like on Twitter 13649797821869178916Twitter 1364979782186917891
Retweet on TwitterMS Coalition Retweeted
iamIOMSNI O M S N@iamIOMSN·
25 Feb

MS Cure Connections Series: The Multiple Sclerosis Patient Journey

Watch it now! https://www.neurologylive.com/cure-connections/the-multiple-sclerosis-patient-journey

Reply on Twitter 1365064761914896385Retweet on Twitter 13650647619148963851Like on Twitter 13650647619148963853Twitter 1365064761914896385
Load More...